ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,367Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 4623

$1.23M Total Retail Price of All Prescriptions

Rank: 81 out of 4623

989 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 989 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 19,497 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CRESTOR 1,404 1,091 1 20
OMEPRAZOLE 1,081 935 2 7
PRAVASTATIN SODIUM 1,043 868 3 11
AMLODIPINE BESYLATE 1,004 849 4 5
LEVOTHYROXINE SODIUM 946 843 5 1
HYDROCODONE-ACETAMINOPHEN 942 645 S3 6 3
LISINOPRIL 875 651 7 4
METFORMIN HCL 728 561 8 6
METOPROLOL TARTRATE 704 543 9 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 506 406 10 19
SIMVASTATIN 488 437 11 2
ATORVASTATIN CALCIUM 467 376 12 12
HYDROCHLOROTHIAZIDE 450 396 13 10
FUROSEMIDE 427 384 14 8
CITALOPRAM HBR 394 287 15 23
ZETIA 390 300 16 92
ZOLPIDEM TARTRATE 375 271 17 18
FLUTICASONE PROPIONATE 359 296 18 32
MELOXICAM 323 261 19 27
ALENDRONATE SODIUM 316 271 20 22
CLONIDINE HCL 316 262 20 40
GABAPENTIN 315 282 22 16
LEVOCETIRIZINE DIHYDROCHLORIDE 295 206 23 221
ALLOPURINOL 272 228 24 37
POTASSIUM CHLORIDE 269 234 25 14
ATENOLOL 259 236 26 28
QUINAPRIL-HYDROCHLOROTHIAZIDE 259 243 10 26 363
LIPITOR 256 200 28 100
FENOFIBRATE 234 141 29 54
SERTRALINE HCL 214 129 30 26
CLOPIDOGREL 205 161 31 31
GLIPIZIDE 200 167 32 49
LOVASTATIN 199 181 33 34
TAMSULOSIN HCL 171 145 34 29
TRAMADOL HCL 162 123 35 15
CARVEDILOL 159 141 36 25
HYDRALAZINE HCL 151 117 37 99
DONEPEZIL HCL 138 135 38 30
AMITRIPTYLINE HCL 138 123 R 38 69
METOPROLOL SUCCINATE 136 117 40 13
GLIMEPIRIDE 133 110 41 38
LOSARTAN-HYDROCHLOROTHIAZIDE 121 89 42 46
TRIAMCINOLONE ACETONIDE 116 76 43 124
NEXIUM 115 72 44 17
PLAVIX 111 89 45 45
DIGOXIN 99 96 46 58
ENALAPRIL MALEATE 98 86 47 41
QUINAPRIL HCL 97 96 48 157
NIASPAN 94 70 49 110
NAPROXEN 93 58 50 63
LYRICA 90 41 51 66
TRIAMTERENE-HCTZ 88 88 52 80
ISOSORBIDE MONONITRATE ER 84 75 53 60
TERAZOSIN HCL 83 80 54 143
PAROXETINE HCL 81 69 55 78
JANUVIA 81 58 55 52
FINASTERIDE 80 68 57 109
CYCLOBENZAPRINE HCL 80 27 R 57 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 63 59 68
PROAIR HFA 76 54 60 64
DILTIAZEM 24HR CD 76 76 60 156
LOSARTAN POTASSIUM 75 56 62 21
SPIRIVA 74 56 63 79
BUPROPION HCL 69 34 64 368
TRAZODONE HCL 66 30 65 42
ADVAIR DISKUS 64 54 66 62
FLUOXETINE HCL 61 35 67 61
PHENYTOIN SODIUM EXTENDED 59 46 68 119
NIFEDIPINE ER 59 51 68 97
GLIPIZIDE ER 59 59 68 86
ROPINIROLE HCL 59 41 68 108
WARFARIN SODIUM 58 55 72 24
DOXAZOSIN MESYLATE 58 58 72 98
SINGULAIR 57 42 74 83
CEFDINIR 56 37 75 129
AMLODIPINE BESYLATE-BENAZEPRIL 54 38 76 55
RANITIDINE HCL 52 25 77 47
IBUPROFEN 52 42 77 65
LEVOTHROID 51 51 79 301
DIOVAN HCT 51 51 79 67
CIPROFLOXACIN HCL 50 46 81 43
POLYETHYLENE GLYCOL 3350 50 49 81 91
BENICAR HCT 50 26 81 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.